Cargando…
Suppression of lusitropy as a disease mechanism in cardiomyopathies
In cardiac muscle the action of adrenaline on β1 receptors of heart muscle cells is essential to adjust cardiac output to the body’s needs. Adrenergic activation leads to enhanced contractility (inotropy), faster heart rate (chronotropy) and faster relaxation (lusitropy), mainly through activation o...
Autores principales: | Marston, Steven, Pinto, Jose Renato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870330/ https://www.ncbi.nlm.nih.gov/pubmed/36698941 http://dx.doi.org/10.3389/fcvm.2022.1080965 |
Ejemplares similares
-
Recent studies of the molecular mechanism of lusitropy due to phosphorylation of cardiac troponin I by protein kinase A
por: Marston, Steven
Publicado: (2022) -
Dynasore Protects Mitochondria and Improves Cardiac Lusitropy in Langendorff Perfused Mouse Heart
por: Gao, Danchen, et al.
Publicado: (2013) -
Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics
por: Keyt, Lucas K., et al.
Publicado: (2022) -
Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy
por: Mittal, Anupam, et al.
Publicado: (2021) -
Systematic analysis of myocardial immune progression in septic cardiomyopathy: Immune-related mechanisms in septic cardiomyopathy
por: Ma, Dunliang, et al.
Publicado: (2023)